2026 Annual Meeting | Industry Therapeutic Update from Pfizer: Migraine Clinical Conversations: The Latest CGRP Receptor Antagonist Data from Pfizer and Insights from Real Patient Cases
Industry Therapeutic Update from Pfizer: Migraine Clinical Conversations: The Latest CGRP Receptor Antagonist Data from Pfizer and Insights from Real Patient Cases
Faculty Disclosures
Wade Cooper, DO
No disclosure on file
Lauren R. Natbony, MD
Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axsome. Dr. Natbony has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Theranica.